Ramy Farid

Insider Reports History

Entity
Individual
Location
Schrodinger, Inc., 120 West 45 Th Street, 17 Th Floor, New York, NY
Signature
/s/ Vanina de Verneuil, Attorney-In-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ramy Farid:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Structure Therapeutics Inc. Director American Depositary Shares 275K $17.2M $62.46 Feb 7, 2023 By Schrodinger, Inc.
Vir Biotechnology, Inc. Director Common Stock 16K $151K $9.46 May 29, 2024 Direct
Vir Biotechnology, Inc. Director Stock Option (Right to Buy) 16K $24.5K $1.53 May 29, 2024 Direct
Structure Therapeutics Inc. Director Ordinary Shares 3.26M Feb 7, 2023 By Schrodinger, Inc.
Schrodinger, Inc. President & CEO, Director Stock Option (right to buy) 87.3K Mar 4, 2024 Direct
Structure Therapeutics Inc. Director Series B Preferred Shares 0 Feb 7, 2023 By Schrodinger, Inc.

Insider Reports Filed by Ramy Farid

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VIR Vir Biotechnology, Inc. May 29, 2024 3 $0 4 May 31, 2024 Director
VIR Vir Biotechnology, Inc. May 29, 2024 0 $0 3 May 31, 2024 Director
SDGR Schrodinger, Inc. Mar 4, 2024 2 $0 4 Mar 5, 2024 President & CEO, Director
SDGR Schrodinger, Inc. Feb 9, 2023 2 $0 4 Feb 10, 2023 President & CEO, Director
GPCR Structure Therapeutics Inc. Feb 7, 2023 3 $4.13M 4 Feb 9, 2023 Director
GPCR Structure Therapeutics Inc. Feb 2, 2023 0 $0 3 Feb 2, 2023 Director
SDGR Schrodinger, Inc. Jan 4, 2023 3 -$1.14M 4 Jan 5, 2023 President & CEO, Director
SDGR Schrodinger, Inc. Feb 9, 2022 1 $0 4 Feb 9, 2022 President & CEO, Director